SynthesisCNS drugs2022

The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis.

Xin Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.